- Revenues of $5,030,116
- Gross margin of 22.1%
- Backlog of signed contracts of $7.7MM
MONTREAL, April 30, 2019 – PyroGenesis Canada Inc. (http://pyrogenesis.com) (TSX-V: PYR) (OTCQB: PYRNF), a high-tech company, (the “Company”, the “Corporation†or “PyroGenesis”) that designs, develops, manufactures and commercializes plasma atomized metal powder, plasma waste-to-energy systems and plasma torch products, today announced its financial and operational results for the fourth quarter and the fiscal year ended December 31, 2018.
“2018 was significantly affected by management’s decision to pursue
strategic partnerships at the expense of revenues. However, as a result,
we have press released imminent contracts in excess of $32MM with
associated future revenues in excess of that,†said Mr. P. Peter
Pascali, President and CEO of PyroGenesis. “Therefore if 2018 was the
year in which the Company successfully positioned itself with unique and
strategic partnerships, geared to effectively accelerate
commercialization, then 2019 is the year that bears the fruit of that
strategy. We strongly recommend that these financials be viewed in this
context.â€
2018 was a year in which PyroGenesis posted:
- Revenues of $5,030,116, a decrease of 30% from $7,192,861 year over year;
- Gross margin of 22.1% a decrease of 21.4% year over year;
- R&D costs of $892K, an increase of 208% from $290K year over
year, the increase is related to torch development and plasma
atomization related expenses;
- Leasehold improvements of $821K were spent to build a clean room for Plasma atomization system;
- A Modified EBITDA loss of $5.3MM compared to a Modified EBITDA loss of $1.45MM year over year;
- Backlog of signed contracts as of the date of this writing is $7.7MM;
- Cash on hand on December 31, 2018 was $645K (December 31, 2017: $623K).
Outlook
2018 was a year in which PyroGenesis successfully positioned each of
its commercial business lines for rapid growth by strategically
partnering with multi-billion-dollar entities who have identified
PyroGenesis’ offerings to be unique, in demand, and of such a commercial
nature as to warrant such unique relationships.
By the end of 2018 PyroGenesis could boast of a unique relationship
with a multi-billion-dollar entity in each of its three commercial
offerings:
| 1) The US Navy within the Military/Environmental sector; |
| 2) A Japanese trading house within the DROSRITETM (tolling) offering; |
| 3) Aubert & Duval within the Additive Manufacturing/3D printing (“AMâ€) offering. |
Most companies would be thankful for one such relationship, but PyroGenesis has successfully developed three.
It became readily apparent to management that partnering with the
right entity could significantly accelerate commercialization in each of
its new business lines. This however, would come with a cost in 2018.
In order to succeed, PyroGenesis would have to dedicate significant
resources to demonstrating the value proposition, and capabilities, to
these entities. This meant that assets which should have been dedicated
to sales now had to be deployed to developing these relationships. This
not only impacted revenues, but it also increased costs of non-paying
projects.
If 2018 was the year in which the Company successfully positioned
itself with unique and strategic partnerships, geared to effectively
accelerate commercialization, then 2019 is the year that bears the fruit
of that strategy.
To date, PyroGenesis has announced that it should be awarded a
two-ship build for its PAWDS unit shortly, for approximately $12.5MM.
Add to this the recently announced potential contract with 1st year
revenues of $20MM ($30-$50MM in subsequent years revenues) and the
impact of this strategy is apparent: over $30 MM in revenues over the
next 18 months. Approximately 6x 2018 revenues.
With these two contracts in hand alone, 2019 will be a profitable year.
2019 should also be the year in which the Company takes steps, outside
of the ordinary course of business, to unlock additional value for
investors.
One such step that has been announced is the spin-off of the
Company’s additive manufacturing capabilities. Management has decided
that, given all it knows, that a spin off at this time should unlock
additional value for investors as it would:
| (i) | Attract
an investor base best suited to the Company’s AM value proposition,
particular business operations, and financial characteristics. There are
large pools of money interested in investing in the AM space, but have
no desire to have their funds comingled with unrelated business lines. A
spin-off would assure them that such funds would be used for AM alone. |
|
| (ii) | Maximize
shareholder value by placing the spin-off in a better position to
generate revenues and develop strategic relationships than had it
remained part of the PyroGenesis stable of technologies |
|
| (iii) | Simplify the offering making it easier for analysts to understand and value it properly. As
it stands now PyroGenesis Additive is part of PyroGenesis Canada Inc’s
offerings which include Drosrite™, US Military, and Purevap™, just to
name a few, and as such makes it complicated to analyze. Last but not
least, a spin-off creates a well understood entity with which interested
parties could joint venture or acquire. |
Another step, which is likewise outside the ordinary course of
business, and is geared to unlocking shareholder value, is the
previously announced up-listing of the Company’s stock to a more senior
exchange other than the one the Company is currently on.
There are other steps, outside the ordinary course of business, that
the Company is considering to increase shareholder value and these will
each be announced in due course.
2019 is positioned to be the first year, of many, that will bear the fruit of strategic decisions made in the recent past.
Financial Summary
Revenue
PyroGenesis recorded revenue of $5,030,116 in the year of 2018,
representing a decrease of 30% compared with $7,192,861 recorded in the
year of 2017.
Revenues recorded in fiscal 2018 were generated primarily from:
| (i) | PUREVAP™ related sales of $1,781,009 (2017 – $2,330,691); |
| (ii) | DROSRITE™ related sales of $1,237,740 (2017 – $98,391)); |
| (iii) | Support services related to PAWDS-Marine Systems supplied to the US Navy $1,451,998 (2017 – $4,337,681). |
| (iv) | Other sales and services $559,369 (2017 – $426,098) |
Cost of Sales and Services and Gross Margins
Cost of sales and services before amortization of intangible assets
was $3,860,493 in 2018, representing a decrease of 5% compared with
$4,065,894 in 2017.
In 2018, employee compensation, direct materials and manufacturing
overhead decreased to $3,590,381 (2017 – $4,338,252) while
subcontracting increased to $364,463 (2017- $98,256). The gross margin
for 2018 was $1,109,297 or 22.1% of revenue compared to a gross margin
of $3,126,967 or 43.5% of revenue for 2017.
The gross margin for 2018, was $1,109,297, or 22.1% of revenue. This
compares with a gross margin of $3,126,961 (43.5% of revenue) for 2017.
As a result of the type of contracts being executed, the nature of
the project activity had a significant impact on the gross margin and
the overall level of cost of sales and services reported in a period, as
well as the composition of the cost of sales and services, as the mix
between labour, materials and subcontracts may be significantly
different. The cost of sales and services for 2018 and 2017 are in line
with management’s expectations.
The amortization of intangible assets of $60,326 in 2018 and $Nil for
2017 relates to patents and deferred development costs. Of note, these
expenses are non-cash items and will be amortized over the duration of
the patent lives.
Selling, General and Administrative Expenses
Included within Selling, General and Administrative expenses
(“SG&Aâ€) are costs associated with corporate administration,
business development, project proposals, operations administration,
investor relations and employee training.
SG&A expenses for 2018 excluding the costs associated with
share-based compensation (a non-cash item in which options vest
principally over a four-year period), were $5,864,528, representing an
increase of 33% compared with $4,394,837 reported for 2017.
The increase in SG&A expenses in 2018 over the same period in 2017 is mainly attributable to the net effect of:
- an increase of 32% in employee compensation due primarily to additional headcount,
- an increase of 55% for professional fees, primarily due to an increase in consulting fees, legal fees and patent expenses,
- an increase of 6% in office and general expenses, due to an increase
in telephone & internet expenses and stationary & office
expenses,
- travel costs increased by 21%, due to an increase in travel abroad,
- depreciation on property and equipment increased by 90% due to
higher amounts of property and equipment being depreciated. In 2018,
depreciation was taken on the Plasma atomization system (previously
asset under development). In 2017 there was no depreciation on asset
under development,
- government grants increased by 100% due to a government grant
contribution for a maximum amount of $350,000 for the period 2018-2020,
- other expenses increased by 35%, primarily due to an increase in marketing expenses, and in sub-contracting expenses.
Separately, share based payments decreased by 11% in 2018 over the
same period in 2017 as a result of the vesting structure of the stock
option plan including the stock options granted in 2018.
Research and Development (“R&Dâ€) Costs
The Company incurred $892,045 of R&D costs, net of government
grants, on internal projects in 2018, an increase of 208% as compared
with $289,851 in 2017. The increase in 2018 is related to torch
development and plasma atomization related expenses.
In addition to internally funded R&D projects, the Company also
incurred R&D expenditures during the execution of client funded
projects. These expenses are eligible for Scientific Research and
Experimental Development (“SR&EDâ€) tax credits. SR&ED tax
credits on client funded projects are applied against cost of sales and
services.
Inventory
The Company’s inventory as at December 31, 2018 was $382,832 which
includes powders, raw material and spare parts compared with $123,735
for the same period in 2017.
Net Comprehensive Loss
The net comprehensive loss for 2018 of $7,845,800 compared to a loss
of $6,174,303, in 2017, represents an increase of 27% year-over-year.
The increase of $1,671,497 in net comprehensive loss in 2018 is
primarily attributable to the factors described above, which have been
summarized as follows:
| (i) | a decrease in product and service-related revenue of $2,162,745 arising in 2018, |
| (ii) | a decrease in cost of
sales and services totaling $145,075, primarily due to an increase in an
increase in subcontracting, a decrease in investment tax credits, and
an increase in amortization of intangible assets. |
| (iii) | an increase in
SG&A expenses of $1,383,927 arising in 2018 primarily due to an
increase in employee compensation, professional fees, travel,
depreciation on property & equipment, and other expenses, |
| (iv) | an increase in R&D
expenses of $602,194 primarily due to the increase in employee
compensation, subcontracting, materials & equipment and other
expenses, |
| (v) | a decrease due to the
settlement of the claim related to the IP debt balance of $3,215,643, an
increase in net finance costs of $883,349 in 2018. |
EBITDA
The EBITDA loss in 2018 was $6,864,461 compared with an EBITDA loss
of $5,558,640 for 2017, representing an increase of 23% year-over-year.
The increase in the EBITDA loss in 2018 compared with 2017 is due to the
increase in comprehensive loss of $1,671,497, offset by an increase
depreciation on property and equipment of $100,685, an increase
amortization of intangible assets of $60,326 and an increase in finance
charges of $204,665.
Adjusted EBITDA loss in 2018 was $6,191,212 compared with an Adjusted
EBITDA loss of $1,583,985 for 2017. The increase of $4,607,227 in the
Adjusted EBITDA loss in 2018 is attributable to an increase in EBITDA
loss of $1,305,821, offset by a decrease of $85,764 in share-based
payments and a decrease in the settlement of a claim related the
long-term debt of $3,215,643.
The Modified EBITDA loss in 2018 was $5,271,749 compared with a
Modified EBITDA loss of $1,445,785 for 2017, representing an increase of
265%. The increase in the Modified EBITDA loss in 2018 is attributable
to the increase as mentioned above in the Adjusted EBITDA of $4,607,227
and a decrease in change of fair value of investments of $781,263.
Liquidity
The Company has incurred, in the last several years, operating losses
and negative cash flows from operations, resulting in an accumulated
deficit of $51,066,540 and a negative working capital of $4,101,429 as
at December 31, 2018 (December 31, 2017 – $43,200,708 and $9,527,105
respectively). Furthermore, as at December 31, 2018, the Company’s
current liabilities and expected level of expenses for the next twelve
months exceed cash on hand of $644,981 (December 31, 2017 – $622,846).
The Company has relied upon external financings to fund its operations
in the past, primarily through the issuance of equity, debt, and
convertible debentures, as well as from investment tax credits.
Separately, PyroGenesis is pleased to announce that Mr. Lelio Lato
has joined the Company as V.P. Finance. As a CPA and CFA with over 20
years of experience, he has worked in various senior management roles
across small cap technology companies with extensive capital markets
knowledge.
About PyroGenesis Canada Inc.
PyroGenesis Canada Inc., a high-tech company, is the world leader in
the design, development, manufacture and commercialization of advanced
plasma processes and products. We provide engineering and manufacturing
expertise, cutting-edge contract research, as well as turnkey process
equipment packages to the defense, metallurgical, mining, advanced
materials (including 3D printing), oil & gas, and environmental
industries. With a team of experienced engineers, scientists and
technicians working out of our Montreal office and our 3,800 m2
manufacturing facility, PyroGenesis maintains its competitive advantage
by remaining at the forefront of technology development and
commercialization. Our core competencies allow PyroGenesis to lead the
way in providing innovative plasma torches, plasma waste processes,
high-temperature metallurgical processes, and engineering services to
the global marketplace. Our operations are ISO 9001:2015 and AS9100D
certified, having been since 1997. PyroGenesis is a publicly-traded
Canadian Corporation on the TSX Venture Exchange (Ticker Symbol: PYR)
and on the OTCQB Marketplace. For more information, please visit www.pyrogenesis.com.
This press release contains certain forward-looking statements,
including, without limitation, statements containing the words “may”,
“plan”, “will”, “estimate”, “continue”, “anticipate”, “intend”,
“expect”, “in the process” and other similar expressions which
constitute “forward- looking information” within the meaning of
applicable securities laws. Forward-looking statements reflect the
Corporation’s current expectation and assumptions and are subject to a
number of risks and uncertainties that could cause actual results to
differ materially from those anticipated. These forward-looking
statements involve risks and uncertainties including, but not limited
to, our expectations regarding the acceptance of our products by the
market, our strategy to develop new products and enhance the
capabilities of existing products, our strategy with respect to research
and development, the impact of competitive products and pricing, new
product development, and uncertainties related to the regulatory
approval process. Such statements reflect the current views of the
Corporation with respect to future events and are subject to certain
risks and uncertainties and other risks detailed from time-to-time in
the Corporation’s ongoing filings with the securities regulatory
authorities, which filings can be found at www.sedar.com, or at www.otcmarkets.com. Actual
results, events, and performance may differ materially. Readers are
cautioned not to place undue reliance on these forward-looking
statements. The Corporation undertakes no obligation to publicly update
or revise any forward- looking statements either as a result of new
information, future events or otherwise, except as required by
applicable securities laws.
Neither the TSX Venture
Exchange, its Regulation Services Provider (as that term is defined in
the policies of the TSX Venture Exchange) nor the OTCQB accepts
responsibility for the adequacy or accuracy of this press release.
SOURCE PyroGenesis Canada Inc.
